Bionovate Technologies Corp (BIIO)

Bionovate Technologies Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2021	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Revenue	-	-	-	-	-	0.01
Revenue Growth (YoY)	-	-	-	-	-	-11.96%
Cost of Revenue	-	-	-	-	-	0
Gross Profit	-	-	-	-	-	0
Selling, General & Admin	0.05	0.05	0.03	0.06	0.12	0.09
Operating Expenses	0.05	0.05	0.03	0.06	0.12	0.09
Operating Income	-0.05	-0.05	-0.03	-0.06	-0.12	-0.09
Interest Expense	-0.06	-0.06	-0.09	-0.15	-0.07	-0.06
Currency Exchange Gain (Loss)	-0	-0	0	-0	0.02	0
EBT Excluding Unusual Items	-0.11	-0.11	-0.12	-0.21	-0.17	-0.15
Gain (Loss) on Sale of Assets	-	-	-	-	-	0.03
Asset Writedown	-	-	-	-	-0.02	-0.23
Other Unusual Items	-	-	-	-	-1.55	-
Pretax Income	-0.11	-0.11	-0.12	-0.21	-1.74	-0.34
Earnings From Continuing Operations	-0.11	-0.11	-0.12	-0.21	-1.74	-0.34
Earnings From Discontinued Operations	-	-	-	-	-	0.02
Net Income to Company	-0.11	-0.11	-0.12	-0.21	-1.74	-0.32
Minority Interest in Earnings	-	-	-	-	-	0
Net Income	-0.11	-0.11	-0.12	-0.21	-1.74	-0.32
Net Income to Common	-0.11	-0.11	-0.12	-0.21	-1.74	-0.32
Shares Outstanding (Basic)	8	8	25	0	0	-
Shares Outstanding (Diluted)	8	8	25	0	0	-
Shares Change (YoY)	-80.53%	-68.98%	15943.66%	145.73%	-	-
EPS (Basic)	-0.01	-0.01	-0.00	-1.34	-27.46	-
EPS (Diluted)	-0.01	-0.01	-0.00	-1.34	-27.46	-
Gross Margin	-	-	-	-	-	16.82%
Operating Margin	-	-	-	-	-	-1628.93%
Profit Margin	-	-	-	-	-	-6002.84%
EBIT	-0.05	-0.05	-0.03	-0.06	-0.12	-0.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.